Course Video

Part 1: Introduction

Dr Jonathan Rosenberg provides an overview of the staging and management of bladder cancer. He introduces the experts, Dr Joaquim Bellmunt and Dr Arlene Siefker-Radtke, and outlines the discussion topics.
PDF icon Download transcript    PDF icon Download slides                                                
03:27 min

Part 2: Immunotherapy

Dr Bellmunt summarizes data presented at ASCO-GU on immunotherapies for urothelial cancer. The experts discuss long-term outcomes with immunotherapy and the role of combination therapies.
PDF icon Download transcript                                                                                   
14:08 min

Part 3: Prognostic Factors

Dr Rosenberg summarizes data presented at ASCO-GU on prognostic factors for immunotherapy outcomes. The experts discuss the relevance and utility of these factors for and in clinical practice.
12:16 min

Part 4: Targeted Therapies

Dr Siefker-Radtke summarizes data presented at ASCO-GU on therapies targeting the FGFR pathway. The experts discuss the management of patients with FGFR-altered tumors.
PDF icon Download transcript                                                                                 
12:49 min

Part 5: Final Discussion

The experts discuss the highlights from ASCO-GU 2018 on the management of patients with bladder cancer; they also provide their outlook on developments in the neoadjuvant setting and on the increasing importance of biomarkers for personalized treatment approaches.
PDF icon Download transcript                                                                               
08:33 min